The 11th edition of this unique industry resource features surprising changes to the top commercial drug list Magellan Rx Management, a division of Magellan Health, Inc. (MGLN), released its eleventh annual Medical Pharmacy Trend ReportTM, featuring a comprehensive view of provider-administered medical benefit drug trendsone of the largest drivers of total specialty drug spend.
. This announcement is for our U.S.$5,000,000,000 Euro Medium Term Note Programme. . [Translation] . May 14, 2021. . To whom it may concern: . Company Name: Mitsui Chemicals, Inc. Name of Representative: Osamu Hashimoto President & CEO Contact: Junichi Inoue General Manager of Corporate Communications Division Phone: +81-3-6253-2100.
Georgia Bio, the states life sciences advocacy and business leadership organization, announced today that Governor Brian Kemps signing of Senate Bill 6 includes language for the Georgia Made Medical Manufacturing Act.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
Log In Required
